personalized medicine
SEngine Precision Medicine, Gustave Roussy to Offer Cancer Drug Sensitivity Testing in Europe
The partners aim to accelerate the implementation of precision oncology in the region, beginning with a clinical trial of colorectal and pancreatic cancer patients.
Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test
The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states.
Weizmann Institute Team Develops System for Personalized Lab Test Interpretation
The system, which is described in Nature Medicine, can help clinicians evaluate lab results that fall within a normal range on a per-patient basis and determine disease risk.
Pillar Biosciences Receives FDA Approval for OncoReveal Dx Lung and Colon Cancer Assay
The IVD, intended for use on the Illumina MiSeq Dx, detects somatic mutations in tumor tissue samples to guide the use of anti-EGFR therapy where indicated.
GenesisCare Takes Minority Stake in Precision Medicine Firm PreludeDx
Earlier this year, the companies signed a deal to expand access to PreludeDx's DCISionRT precision medicine breast cancer test in Australia and the US.